deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT00595088

Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer

Phase 2b, Multicenter Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer

Sponsor: Anchiano Therapeutics Israel Ltd.

Conditions Superficial Bladder Cancer
Interventions BC-819/PEI
Updated 10 times since 2017 Last updated: Apr 8, 2019 Started: Jan 31, 2008 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00595088, this PHASE2 trial focuses on Superficial Bladder Cancer and remains completed. Sponsored by Anchiano Therapeutics Israel Ltd., it has been updated 10 times since 2008, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotUnknown Status~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotUnknown Status~Feb 2019 – ~May 2019 · 3 months · monthly snapshotUnknown Status~May 2019 – ~Jan 2021 · 20 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE2

▶ Show 5 earlier versions

  1. May 2019 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Unknown Status → Completed

  2. Feb 2019 — May 2019 [monthly]

    Unknown Status PHASE2

  3. Jun 2018 — Feb 2019 [monthly]

    Unknown Status PHASE2

  4. Feb 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

  5. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE2

    First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Anchiano Therapeutics Israel Ltd.
Data source: Anchiano Therapeutics Israel Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations